CELYAD ONCOLOGY SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.319 EUR | +5.11% |
|
+2.90% | -18.21% |
| Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELYAD ONCOLOGY SA | Other Biotechnology & Medical Research | +5.11% | +2.90% | -18.21% | -47.70% | -98.20% | 13.51M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CYAD Stock
- Charts Celyad Oncology SA
- Comparison Chart